Dianna Sue Howard, M.D.
Professor, Hematology & Oncology
Academic: 336-716-4464 | Department: 336-716-4464
Acute graft-versus-host disease in the setting of T cell depletion: validation of a new agvhd risk score [abstract]. Saeed H, Slone S, Yalamanchi S, Becton T, Monohan G, Howard D, Herzig R, Hildebrandt GC.. Biol Blood Marrow Transplant. 2016;22(3 Suppl 1):S410-S411.
Timing of salvage therapy and autologous hematopoietic cell transplant in relapsed hodgkin and non hodgkin lymphoma [abstract]. Lamar ZS, Fino N, Hurd D, Howard D, McIver ZA, Phillips GL, Vaidya R.. Biol Blood Marrow Transplant. 2016;22(3 Suppl 1):S127-S128.
Simultaneous quantitation of oxidized and reduced glutathione via LC-MS/MS: an insight into the redox state of hematopoietic stem cells. Carroll D, Howard D, Zhu H, Paumi CM, Vore M, Bondada S, Liang Y, Wang C, St Clair DK.. Free Radic Biol Med. 2016;97():85-94.
Activity of the mitochondrial metabolism inhibitor cpi-613 in combination with high dose Ara-C (HDAC) and mitoxantrone in high risk relapsed or refractory acute myeloid leukemia (AML) [abstract]. Pardee TS, Stadelman K, Isom S, Ellis LR, Berenzon D, Hurd DD, Howard DS, Harrelson R, Manuel M, Dralle S, Lyerly S, Powell BL.. J Clin Oncol. 2015;33(15 Suppl):7015.
The mitochondrial metabolism inhibitor Cpi-613 in combination with high dose Ara-C (HDAC) and mitoxantrone is highly active in poor risk relapsed or refractory acute myeloid leukemia (AML) [abstract]. Pardee T, Pladna K, Isom S, Ellis LR, Berenzon D, Howard D, Manuel M, Dralle S, Hurd DD, Lyerly S, Powell BL.. Blood. 2015;126(23):2556.
Feasibility of a symptom-adapted physical activity intervention during induction chemotherapy for older adults with acute myeloid leukemia (AML) [abstract]. Klepin HD, Tooze J, Pardee T, Ellis LR, Berenzon D, Howard D, Demark-Wahnefried W, Mihalko S, Rejeski WJ, Powell BL, Kritchevsky S.. Blood. 2015;126(23):2102.
A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: a report from the Children's Oncology Group. Horton TM, Perentesis JP, Gamis AS, Alonzo TA, Gerbing RB, Ballard J, Adlard K, Howard DS, Smith FO, Jenkins G, Kelder A, Schuurhuis GJ, Moscow JA.. Pediatr Blood Cancer. 2014;61(10):1754-1760.
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.
Professor, Hematology & Oncology
Acute and Chronic Leukemia, Acute Leukemias, Myelodysplastic Syndromes, Blood and Marrow Transplant, Hematologic Malignancies, Multiple Myeloma, Hematopoietic Stem Cell Transplantation, Bone Marrow and Stem Cell Transplantation, Leukemia
The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.
Best MD I've ever had. Highly respected by staff.
Dr. Howard and her entire team have been great from the beginning of my treatment. I have always gone to Novant until they referred me out for bone marrow transplant. my original plan before meeting Dr. Howard was to get a second opinion before deciding where my Bmt would take please. when I met with Dr Howard at my first visit that all changed. She was so informative and compassionate, it was so obvious that she studied all my Novant records before seeing me because she new everything including surgeries in the past. I was more than impressed. after we saw her we met with other team members that were also very informative about what comes next. needless to say I walked out of there knowing there was no need to see anyone else because I wanted her to take care of me. since that time she has been great. I can honestly say that she is the best Dr. I have ever had. this whole process has moved me from being all about Novant Heath Cancer center to Baptist all the way this is due to Dr Howard and her entire team. in the future all my referrals will go to Baptist.
I would actually rate Dr. Howard and Mary Lynch as excellent if that rating was available. Besides being very experienced and knowledgeable, they are also very caring and kind.
Dr. Howard and Dr. Lamar has actually been the best provider I have ever seen. I am impressed by the time they take and the care and concern they showed.
*Dr. Howard provides excellent care.
*Dr. Howard is fantastic. She is very knowledgeable and kind. Informative beyond expectation.
Could not ask for a better provider.
*Dr. Howard is wonderful in ALL aspects.
Have every confidence in *Dr. Howard's opinion and care.
*Dr. Howard is excellent! She listens, explains, & is understanding & passionate.
I was very happy with my first visit with *Dr. Howard.